(Q35073549)

6 August 2017

title

Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study (English)

1 reference

6 August 2017

0 references

1 reference

1

Mats B Humble

1 reference

6 August 2017

2

Kerstin Uvnäs-Moberg

1 reference

6 August 2017

Ingemar Engström

3

1 reference

6 August 2017

Susanne Bejerot

series ordinal

4

1 reference

6 August 2017

publication date

23 December 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

13

1 reference

6 August 2017

page(s)

344

1 reference

Abnormal corticostriatal-limbic functional connectivity in obsessive-compulsive disorder during reward processing and resting-state

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Neuromodulation by oxytocin and vasopressin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin during the initial stages of romantic attachment: relations to couples' interactive reciprocity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Modulating social behavior with oxytocin: how does it work? What does it mean?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin: the great facilitator of life.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Neuroanatomical and cellular substrates of hypergrooming induced by microinjection of oxytocin in central nucleus of amygdala, an experimental model of compulsive behavior

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Pharmacotherapies in the management of obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin--anatomy and functional assignments: a minireview

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Dendritic peptide release and peptide-dependent behaviours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Obsessions and compulsions in Asperger syndrome and high-functioning autism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Possible role of neuropeptides in obsessive compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin, vasopressin, and autism: is there a connection?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

The role of central oxytocin in obsessive compulsive disorder and related normal behavior

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Intranasal oxytocin in obsessive-compulsive disorder.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Increased plasma levels of oxytocin in response to afferent electrical stimulation of the sciatic and vagal nerves and in response to touch and pinch in anaesthetized rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Obsessive-compulsive disorder and serotonin: is there a connection?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Oxytocin in obsessive compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

A New Depression Scale Designed to be Sensitive to Change

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Obsessive compulsive behaviour in autism--towards an autistic-obsessive compulsive syndrome?

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

An autistic dimension: a proposed subtype of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Obsessive-compulsive disorder with poor insight: a three-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Comorbid obsessive-compulsive personality disorder in obsessive-compulsive disorder (OCD): a marker of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Evoked axonal oxytocin release in the central amygdala attenuates fear response

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Central and peripheral release of oxytocin following chronic homotypic stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Oxytocin may mediate the benefits of positive social interaction and emotions

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Autistic traits in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Chemical coding of GABA(B) receptor-immunoreactive neurones in hypothalamic regions regulating body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Low CSF oxytocin reflects high intent in suicide attempters

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Anxiety, cortisol, and attachment predict plasma oxytocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Oxytocin in postnatally depressed mothers: its influence on mood and expressed emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Repeated intranasal oxytocin administration in early life dysregulates the HPA axis and alters social behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Urinary oxytocin and social bonding in related and unrelated wild chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Serotonin receptors involved in vasopressin and oxytocin secretion

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877985

Obsessive-compulsive disorder

27 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-344

Oxytocin as a possible mediator of SSRI-induced antidepressant effects

21 January 2018

1 reference

12 December 2020

Normal CSF oxytocin and NPY levels in OCD

1 reference

12 December 2020

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

1 reference

12 December 2020

Evidence-based pharmacotherapy of obsessive-compulsive disorder

1 reference

12 December 2020

Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder

1 reference

12 December 2020

Clomipramine in obsessive-compulsive disorder

1 reference

12 December 2020

Clomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'

1 reference

12 December 2020

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

1 reference

12 December 2020

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

12 December 2020

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats

1 reference

12 December 2020

Intranasal oxytocin in obsessive-compulsive disorder

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-13-344

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cpfe7c2p7rd57bm6dbph33waf4

30 July 2022

Dimensions Publication ID

1029038691

0 references

Fatcat ID

release_cpfe7c2p7rd57bm6dbph33waf4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cpfe7c2p7rd57bm6dbph33waf4

30 July 2022

https://api.fatcat.wiki/v0/release/cpfe7c2p7rd57bm6dbph33waf4

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/cpfe7c2p7rd57bm6dbph33waf4

1 reference

30 July 2022